214 related articles for article (PubMed ID: 33549634)
1. 15-Year Experience with Multimodality Therapy Including Esophagectomy for Elderly Patients with Locoregional Esophageal Cancer.
Sawyer WP; Luo X; Welch AM; Bolton NM; Brown R; Bolton JS
J Am Coll Surg; 2021 Apr; 232(4):580-588. PubMed ID: 33549634
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the esophagus and esophagogastric junction in patients older than 70 years: results of neoadjuvant radiochemotherapy followed by transthoracic esophagectomy.
Camerlo A; D'Journo XB; Ouattara M; Trousse D; Doddoli C; Thomas PA
J Visc Surg; 2012 Jun; 149(3):e203-10. PubMed ID: 22633088
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer.
Cooper L; Dezube AR; De León LE; Kucukak S; Mazzola E; Dumontier C; Mamon H; Enzinger P; Jaklitsch MT; Frain LN; Wee JO
Eur J Surg Oncol; 2021 Oct; 47(10):2667-2674. PubMed ID: 33895020
[TBL] [Abstract][Full Text] [Related]
4. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
5. New-onset atrial fibrillation post-surgery for esophageal and junctional cancer: incidence, management, and impact on short- and long-term outcomes.
Mc Cormack O; Zaborowski A; King S; Healy L; Daly C; OʼFarrell N; Donohoe CL; Ravi N; Reynolds JV
Ann Surg; 2014 Nov; 260(5):772-8; discussion 778. PubMed ID: 25379848
[TBL] [Abstract][Full Text] [Related]
6. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years.
Internullo E; Moons J; Nafteux P; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Lerut T
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1096-104. PubMed ID: 18407509
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
[TBL] [Abstract][Full Text] [Related]
8. The Short- and Long-term Outcomes of Esophagectomy for Esophageal Cancer in Patients Older than 75 Years.
Aoyama T; Hara K; Kazama K; Atsumi Y; Tamagawa H; Tamagawa A; Machida D; Komori K; Maezawa Y; Kano K; Hashimoto I; Oshima T; Murakawa M; Numata M; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Feb; 40(2):1087-1093. PubMed ID: 32014958
[TBL] [Abstract][Full Text] [Related]
9. Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer.
Sihag S; Ku GY; Tan KS; Nussenzweig S; Wu A; Janjigian YY; Jones DR; Molena D
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):836-843.e1. PubMed ID: 33485662
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70.
Blom RL; van Heijl M; Klinkenbijl JH; Bergman JJ; Wilmink JW; Richel DJ; Hulshof MC; Reitsma JB; Busch OR; van Berge Henegouwen MI
Dis Esophagus; 2013 Jul; 26(5):510-6. PubMed ID: 22925313
[TBL] [Abstract][Full Text] [Related]
11. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options.
Mota FC; Cecconello I; Takeda FR; Tustumi F; Sallum RAA; Bernardo WM
Int J Surg; 2018 Jun; 54(Pt A):176-181. PubMed ID: 29730075
[TBL] [Abstract][Full Text] [Related]
13. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.
Sawas T; Manrique GC; Iyer PG; Wang KK; Katzka DA
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1756-1762. PubMed ID: 30267861
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
15. Postchemoradiation resected locally advanced esophageal and gastroesophageal junction carcinoma: long-term outcome with or without intraoperative radiotherapy.
Calvo FA; Sole CV; Obregón R; Gómez-Espí M; Lozano MA; Gonzalez-Bayon L; García-Sabrido JL
Ann Surg Oncol; 2013 Jun; 20(6):1962-9. PubMed ID: 23254690
[TBL] [Abstract][Full Text] [Related]
16. Age and Charlson Comorbidity Index score are not independent risk factors for severe complications after curative esophagectomy for esophageal cancer: a Dutch population-based cohort study.
Baranov N; Claassen L; van Workum F; Rosman C
Surg Oncol; 2022 Aug; 43():101789. PubMed ID: 35792370
[TBL] [Abstract][Full Text] [Related]
17. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
Ruol A; Portale G; Castoro C; Merigliano S; Cagol M; Cavallin F; Chiarion Sileni V; Corti L; Rampado S; Costantini M; Ancona E
Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
[TBL] [Abstract][Full Text] [Related]
18. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
19. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
[TBL] [Abstract][Full Text] [Related]
20. Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer.
Nederlof N; Slaman AE; van Hagen P; van der Gaast A; Slankamenac K; Gisbertz SS; van Lanschot JJ; Wijnhoven BP; van Berge Henegouwen MI;
Ann Surg Oncol; 2016 Nov; 23(12):3964-3971. PubMed ID: 27301849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]